Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose zopiclone in obstructive sleep apnoea
ACTRN12617000988358Phase 2Completed
- Sponsor
- Neuroscience Research Australia
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of zopiclone in obstructive sleep apnea hypopnea syndrome (OSAHS) (2 arms), sponsored by Neuroscience Research Australia. Primary endpoint: Change in sleep apnoea severity. Started Jul 2017; status: completed.
02
Drugs
zopiclone
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ACTRN12617000988358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000988358.